Discontinuation report ADLYXINE

Last updated on 2023-05-16 History
Report ID 192514
Drug Identification Number 02464276
Brand name ADLYXINE
Common or Proper name ADLYXINE
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LIXISENATIDE
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1
ATC code A10BJ
ATC description
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2023-05-15
Remaining supply date
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Company business decision
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2023-05-16 English Compare
v2 2023-05-15 French Compare
v1 2023-05-15 English Compare

Showing 1 to 3 of 3